Package 68180-340-13

{"route": ["ORAL"], "spl_id": "063d2028-f666-4304-8cd3-21d882d8c97f", "openfda": {"unii": ["Q326023R30"], "rxcui": ["1989081"], "spl_set_id": ["540b6f6a-79f3-4681-8c2a-268cf7cecbc9"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (68180-340-13)  / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK", "package_ndc": "68180-340-13", "marketing_start_date": "20250818"}], "brand_name": "Bosentan", "product_id": "68180-340_063d2028-f666-4304-8cd3-21d882d8c97f", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Endothelin Receptor Antagonist [EPC]", "Endothelin Receptor Antagonists [MoA]"], "product_ndc": "68180-340", "generic_name": "Bosentan", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bosentan", "active_ingredients": [{"name": "BOSENTAN", "strength": "32 mg/1"}], "application_number": "ANDA213154", "marketing_category": "ANDA", "marketing_start_date": "20250818", "listing_expiration_date": "20261231"}